aiming to mount a challenge to Amgen's $2.3 billion oral psoriasis therapy Otezla (apremilast). BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by ...

The start of regulatory reviews is also a shot across the bows of Amgen, as deucravacitinib outperformed its rival drug Otezla (apremilast) in a clinical trial reported earlier this year.

Some of its largest drugs include Enbrel for treatment of several autoimmune diseases, Prolia for osteoporosis, XGEVA for strengthening bones, Otezla for managing inflammation, and Repatha for ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Find the latest Range Cancer Therapeutics Index ETF (CNCR) stock quote, history, news and other vital information to help you with your stock trading and investing.

Join Drs Ginette Okoye and Rebecca Manno as they discuss the connection between HS and arthritis, practice pearls, and novel insights uncovered from clinic work in the USVI.

Several new treatment modalities with different mechanisms of action have been studied in patients with Behçet’s syndrome (BS). The aim of the current effort was to update the recommendations in the ...